Optimization of Circulating Biomarkers of Obatoclax-Induced Cell Death in Patients with Small Cell Lung Cancer

מאת Dean, Emma J, Cummings, Jeff, Roulston, Anne, Berger, Mark, Ranson, Malcolm, Blackhall, Fiona, Dive, Caroline
יצא לאור 2011

DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer

מאת Board, Ruth E, Knight, Lucy, Greystoke, Alastair, Blackhall, Fiona H, Hughes, Andrew, Dive, Caroline, Ranson, Malcolm
יצא לאור 2008

Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer

מאת Hou, Jian-Mei, Krebs, Matthew, Ward, Tim, Sloane, Robert, Priest, Lynsey, Hughes, Andrew, Clack, Glen, Ranson, Malcolm, Blackhall, Fiona, Dive, Caroline
יצא לאור 2011

Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy

מאת Hou, Jian-Mei, Greystoke, Alastair, Lancashire, Lee, Cummings, Jeff, Ward, Tim, Board, Ruth, Amir, Eitan, Hughes, Sarah, Krebs, Matthew, Hughes, Andrew, Ranson, Malcolm, Lorigan, Paul, Dive, Caroline, Blackhall, Fiona H.
יצא לאור 2009

Molecular Imaging and Pharmacokinetic Analysis of Carbon-11 Labeled Antisense Oligonucleotide LY2181308 in Cancer Patients

מאת Saleem, Azeem, Matthews, Julian C., Ranson, Malcolm, Callies, Sophie, André, Valérie, Lahn, Michael, Dickinson, Claire, Prenant, Christian, Brown, Gavin, McMahon, Adam, Talbot, Denis C., Jones, Terry, Price, Patricia M.
יצא לאור 2011

Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours

מאת Evans, T. R. Jeffry, Dean, Emma, Molife, L. Rhoda, Lopez, Juanita, Ranson, Malcolm, El-Khouly, Fatima, Zubairi, Ishtiaq, Savulsky, Claudio, Reyderman, Larisa, Jia, Yan, Sweeting, Lorna, Greystoke, Alastair, Barriuso, Jorge, Kristeleit, Rebecca
הוצא לאור ב Br J Cancer (2019)

First-in-human pharmacokinetic and pharmacodynamic study of the dual m-TORC 1/2 inhibitor, AZD2014

מאת Basu, Bristi, Dean, Emma, Puglisi, Martina, Greystoke, Alastair, Ong, Michael, Burke, Wendy, Cavallin, Maria, Bigley, Graham, Womack, Christopher, Harrington, Elizabeth A, Green, Stephen, Oelmann, Elisabeth, de Bono, Johann S, Ranson, Malcolm, Banerji, Udai
הוצא לאור ב Clin Cancer Res (2015)

Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer

מאת Rodon, Jordi, PérezFidalgo, Alejandro, Krop, Ian E., Burris, Howard, Guerrero-Zotano, Angel, Britten, Carolyn D., Becerra, Carlos, Schellens, Jan, Richards, Donald A., Schuler, Martin, Abu-Khalaf, Maysa, Johnson, Faye M., Ranson, Malcolm, Edenfield, Jeff, Silva, Antonio P., Hackl, Wolfgang, Quadt, Cornelia, Demanse, David, Duval, Vincent, Baselga, Jose
הוצא לאור ב Cancer Chemother Pharmacol (2018)

Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer

מאת Rudin, Charles M., Hann, Christine L., Garon, Edward B., Ribeiro de Oliveira, Moacyr, Bonomi, Philip D., Camidge, D. Ross, Chu, Quincy, Giaccone, Giuseppe, Khaira, Divis, Ramalingam, Suresh S., Ranson, Malcolm R., Dive, Caroline, McKeegan, Evelyn M., Chyla, Brenda J., Dowell, Barry L., Chakravartty, Arunava, Nolan, Cathy E., Rudersdorf, Niki, Busman, Todd A., Mabry, Mack H., Krivoshik, Andrew P., Humerickhouse, Rod A., Shapiro, Geoffrey I., Gandhi, Leena
יצא לאור 2012

AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer

מאת Cross, Darren A. E., Ashton, Susan E., Ghiorghiu, Serban, Eberlein, Cath, Nebhan, Caroline A., Spitzler, Paula J., Orme, Jonathon P., Finlay, M. Raymond V., Ward, Richard A., Mellor, Martine J., Hughes, Gareth, Rahi, Amar, Jacobs, Vivien N., Brewer, Monica Red, Ichihara, Eiki, Sun, Jing, Jin, Hailing, Ballard, Peter, Al-Kadhimi, Katherine, Rowlinson, Rachel, Klinowska, Teresa, Richmond, Graham H. P., Cantarini, Mireille, Kim, Dong-Wan, Ranson, Malcolm R., Pao, William
הוצא לאור ב Cancer Discov (2014)